348 related articles for article (PubMed ID: 24102852)
1. Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.
Calès P; Boursier J; Ducancelle A; Oberti F; Hubert I; Hunault G; de Lédinghen V; Zarski JP; Salmon D; Lunel F;
Liver Int; 2014 Jul; 34(6):907-17. PubMed ID: 24102852
[TBL] [Abstract][Full Text] [Related]
2. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
Boursier J; de Ledinghen V; Zarski JP; Rousselet MC; Sturm N; Foucher J; Leroy V; Fouchard-Hubert I; Bertrais S; Gallois Y; Oberti F; Dib N; Calès P
Am J Gastroenterol; 2011 Jul; 106(7):1255-63. PubMed ID: 21468012
[TBL] [Abstract][Full Text] [Related]
3. Cirrhosis Diagnosis and Liver Fibrosis Staging: Transient Elastometry Versus Cirrhosis Blood Test.
Calès P; Boursier J; Oberti F; Bardou D; Zarski JP; de Lédinghen V;
J Clin Gastroenterol; 2015 Jul; 49(6):512-9. PubMed ID: 24828359
[TBL] [Abstract][Full Text] [Related]
4. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.
Boursier J; Vergniol J; Sawadogo A; Dakka T; Michalak S; Gallois Y; Le Tallec V; Oberti F; Fouchard-Hubert I; Dib N; Rousselet MC; Konaté A; Amrani N; de Ledinghen V; Calès P
Liver Int; 2009 Nov; 29(10):1507-15. PubMed ID: 19725892
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
[TBL] [Abstract][Full Text] [Related]
6. Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C.
Boursier J; Bertrais S; Oberti F; Gallois Y; Fouchard-Hubert I; Rousselet MC; Zarski JP; Calès P
BMC Gastroenterol; 2011 Nov; 11():132. PubMed ID: 22129438
[TBL] [Abstract][Full Text] [Related]
7. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
Boursier J; Bacq Y; Halfon P; Leroy V; de Ledinghen V; de Muret A; Bourlière M; Sturm N; Foucher J; Oberti F; Rousselet MC; Calès P
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):28-38. PubMed ID: 19060630
[TBL] [Abstract][Full Text] [Related]
8. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
Calès P; Halfon P; Batisse D; Carrat F; Perré P; Penaranda G; Guyader D; d'Alteroche L; Fouchard-Hubert I; Michelet C; Veillon P; Lambert J; Weiss L; Salmon D; Cacoub P
J Hepatol; 2010 Aug; 53(2):238-44. PubMed ID: 20493576
[TBL] [Abstract][Full Text] [Related]
9. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.
Boursier J; de Ledinghen V; Zarski JP; Fouchard-Hubert I; Gallois Y; Oberti F; Calès P;
Hepatology; 2012 Jan; 55(1):58-67. PubMed ID: 21898504
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
[TBL] [Abstract][Full Text] [Related]
11. Acoustic radiation force impulse elastography, FibroScan®, Forns' index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methods.
Dong DR; Hao MN; Li C; Peng Z; Liu X; Wang GP; Ma AL
Mol Med Rep; 2015 Jun; 11(6):4174-82. PubMed ID: 25651500
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
Zarski JP; Sturm N; Guechot J; Paris A; Zafrani ES; Asselah T; Boisson RC; Bosson JL; Guyader D; Renversez JC; Bronowicki JP; Gelineau MC; Tran A; Trocme C; De Ledinghen V; Lasnier E; Poujol-Robert A; Ziegler F; Bourliere M; Voitot H; Larrey D; Rosenthal-Allieri MA; Fouchard Hubert I; Bailly F; Vaubourdolle M;
J Hepatol; 2012 Jan; 56(1):55-62. PubMed ID: 21781944
[TBL] [Abstract][Full Text] [Related]
13. [Non invasive markers using for the assessment of fibrosis in hepatitis C].
Zarski JP; Bedossa P; Bronowicki JP; Doffoel M; Poynard T
Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S34-9. PubMed ID: 17965633
[TBL] [Abstract][Full Text] [Related]
14. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.
Boursier J; Guillaume M; Leroy V; Irlès M; Roux M; Lannes A; Foucher J; Zuberbuhler F; Delabaudière C; Barthelon J; Michalak S; Hiriart JB; Peron JM; Gerster T; Le Bail B; Riou J; Hunault G; Merrouche W; Oberti F; Pelade L; Fouchard I; Bureau C; Calès P; de Ledinghen V
J Hepatol; 2019 Aug; 71(2):389-396. PubMed ID: 31102719
[TBL] [Abstract][Full Text] [Related]
15. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
[TBL] [Abstract][Full Text] [Related]
16. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.
Gaia S; Campion D; Evangelista A; Spandre M; Cosso L; Brunello F; Ciccone G; Bugianesi E; Rizzetto M
Liver Int; 2015 Aug; 35(8):2027-35. PubMed ID: 25495478
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.
Leroy V; Sturm N; Faure P; Trocme C; Marlu A; Hilleret MN; Morel F; Zarski JP
J Hepatol; 2014 Jul; 61(1):28-34. PubMed ID: 24631902
[TBL] [Abstract][Full Text] [Related]
19. Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.
Boursier J; Brochard C; Bertrais S; Michalak S; Gallois Y; Fouchard-Hubert I; Oberti F; Rousselet MC; Calès P
Aliment Pharmacol Ther; 2014 Jul; 40(2):178-88. PubMed ID: 24889599
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C.
Calès P; de Ledinghen V; Halfon P; Bacq Y; Leroy V; Boursier J; Foucher J; Bourlière M; de Muret A; Sturm N; Hunault G; Oberti F
Liver Int; 2008 Dec; 28(10):1352-62. PubMed ID: 18492022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
